Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration (Oral, Parenteral, Others), Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

Report
260 Pages
July 2023
Region: Global
Azoth Analytics
ID: 5518202

Scope of the Report

The report analyses the Idiopathic Pulmonary Fibrosis Market by Value (USD Million)
The report presents the analysis of Idiopathic Pulmonary Fibrosis market for the historical period of 2018-2022, the estimated year 2023 and the forecast period of 2024-2029
The report analyses the Idiopathic Pulmonary Fibrosis Market by Drug Type (Pirfenidone, Nintedanib, Other drugs)
The report analyses the Idiopathic Pulmonary Fibrosis Market by Route of Administration (Oral, Parenteral, Other ROA)
The report analyses the Idiopathic Pulmonary Fibrosis Market by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel)
The Global Idiopathic Pulmonary Fibrosis Market has been analysed by countries (United States, Canada, United Kingdom, Germany, France, Italy, Spain, China, South Korea, India, Japan)
The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Idiopathic Pulmonary Fibrosis Type, by Idiopathic Pulmonary Fibrosis Form, by Sales Channel
Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Boehringer Ingelheim, F. Hoffmann-La Roche AG , Cipla Ltd. , Shionogi & Co., Ltd., Bristol-Myers Squibb Co., United Therapeutics, FibroGen, Inc., Pliant Therapeutics, Galecto Inc. , CSL Behring.

1. Market Background

1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology

2. Strategic Recommendations

2.1 Enhancing R&D operations for development of novel treatments
2.2 Improving access to treatment

3. Global Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)

3.1 Impact Analysis of Macro Economic Factors on Idiopathic Pulmonary Fibrosis Market
3.2 Most bothersome IPF symptom
3.3 Idiopathic Pulmonary Fibrosis diagnosed prevalent cases
3.4 Competitive landscape for IPF drugs in Pipeline
3.5 Chronic Cough due to IPF
3.6 Idiopathic pulmonary fibrosis: fact sheet
3.7 Pathophysiology of Chronic Cough due to IPF
3.8 Comorbidities Associated with Chronic Cough in IPF
3.9 Global Idiopathic Pulmonary Fibrosis Market: Dashboard
3.10 Global Idiopathic Pulmonary Fibrosis Market: Market Value Assessment, 2018-2028 (USD Million)
3.11 Impact of COVID-19 on Global Idiopathic Pulmonary Fibrosis Market
3.12 Global Idiopathic Pulmonary Fibrosis Market Segmentation: By Drug Type
3.12.1 Global Idiopathic Pulmonary Fibrosis Market, By Drug Type Type Overview
3.12.2 Global Idiopathic Pulmonary Fibrosis Market Size, By Pirfenidone, By Value, 2018H-2028F (USD Million & CAGR)
3.12.3 Global Idiopathic Pulmonary Fibrosis Market Size, By Nintedanib, By Value, 2018H-2028F (USD Million & CAGR)
3.12.4 Global Idiopathic Pulmonary Fibrosis Market Size, By Other drugs, By Value, 2018H-2028F (USD Million & CAGR)
3.13 Global Idiopathic Pulmonary Fibrosis Market Segmentation: By Route of Administration
3.13.1 Global Idiopathic Pulmonary Fibrosis Market, By Route of Administration Overview
3.13.2 Global Idiopathic Pulmonary Fibrosis Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
3.13.3 Global Idiopathic Pulmonary Fibrosis Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
3.13.4 Global Idiopathic Pulmonary Fibrosis Market Size, By Other ROA, By Value, 2018H-2028F (USD Million & CAGR)
3.14 Global Idiopathic Pulmonary Fibrosis Market Segmentation: By Distribution Channel
3.14.1 Global Idiopathic Pulmonary Fibrosis Market, By Distribution Channel Overview
3.14.2 Global Idiopathic Pulmonary Fibrosis Market Size, By Hospital Pharmacies By Value, 2018H-2028F (USD Million & CAGR)
3.14.3 Global Idiopathic Pulmonary Fibrosis Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
3.14.4 Global Idiopathic Pulmonary Fibrosis Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)

4. Global Idiopathic Pulmonary Fibrosis Market, Regional Analysis

4.1 Regional Coverage of the Study

5. Americas Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)

5.1 Americas Idiopathic Pulmonary Fibrosis Market: Snapshot
5.2 Americas Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.3 Americas Idiopathic Pulmonary Fibrosis Market: Key Factors
5.4 Americas Idiopathic Pulmonary Fibrosis Market Segmentation: By Drug Type
5.4.1 Americas Idiopathic Pulmonary Fibrosis Market, By Drug Type Overview
5.4.2 Americas Idiopathic Pulmonary Fibrosis Market Size, By Pirfenidone, By Value, 2018H-2028F (USD Million & CAGR)
5.4.3 Americas Idiopathic Pulmonary Fibrosis Market Size, By Nintedanib, By Value, 2018H-2028F (USD Million & CAGR)
5.4.4 Americas Idiopathic Pulmonary Fibrosis Market Size, By Other drugs, By Value, 2018H-2028F (USD Million & CAGR)
5.5 Americas Idiopathic Pulmonary Fibrosis Market Segmentation: By Route of Administration
5.5.1 Americas Idiopathic Pulmonary Fibrosis Market, By Route of Administration Overview
5.5.2 Americas Idiopathic Pulmonary Fibrosis Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
5.5.3 Americas Idiopathic Pulmonary Fibrosis Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
5.5.4 Americas Idiopathic Pulmonary Fibrosis Market Size, By Other ROA, By Value, 2018H-2028F (USD Million & CAGR)
5.6 Americas Idiopathic Pulmonary Fibrosis Market Segmentation: By Distribution Channel
5.6.1 Americas Idiopathic Pulmonary Fibrosis Market, By Distribution Channel Overview
5.6.2 Americas Idiopathic Pulmonary Fibrosis Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
5.6.3 Americas Idiopathic Pulmonary Fibrosis Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
5.6.4 Americas Idiopathic Pulmonary Fibrosis Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
5.7 Americas Idiopathic Pulmonary Fibrosis Market Segmentation: By Country
5.7.1 United States Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.7.1.1 United States Idiopathic Pulmonary Fibrosis Market, By Drug Type
5.7.1.2 United States Idiopathic Pulmonary Fibrosis Market, By Route of Administration
5.7.1.3 United States Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
5.7.2 Canada Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.7.2.1 Canada Idiopathic Pulmonary Fibrosis Market, By Drug Type
5.7.2.2 Canada Idiopathic Pulmonary Fibrosis Market, By Route of Administration
5.7.2.3 Canada Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
5.7.3 Rest of Americas Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.7.3.1 Rest of Americas Idiopathic Pulmonary Fibrosis Market, By Drug Type
5.7.3.2 Rest of Americas Idiopathic Pulmonary Fibrosis Market, By Route of Administration
5.7.3.3 Rest of Americas Idiopathic Pulmonary Fibrosis Market, By Route of Administration

6. Europe Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)

6.1 Europe Idiopathic Pulmonary Fibrosis Market: Snapshot
6.2 Europe Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.3 Europe Idiopathic Pulmonary Fibrosis Market: Key Factors
6.4 Europe Idiopathic Pulmonary Fibrosis Market Segmentation: By Drug Type
6.4.1 Europe Idiopathic Pulmonary Fibrosis Market, By Drug Type Overview
6.4.2 Europe Idiopathic Pulmonary Fibrosis Market Size, By Pirfenidone, By Value, 2018H-2028F (USD Million & CAGR)
6.4.3 Europe Idiopathic Pulmonary Fibrosis Market Size, By Nintedanib, By Value, 2018H-2028F (USD Million & CAGR)
6.4.4 Europe Idiopathic Pulmonary Fibrosis Market Size, By Other drugs, By Value, 2018H-2028F (USD Million & CAGR)
6.5 Europe Idiopathic Pulmonary Fibrosis Market Segmentation: By Route of Administration
6.5.1 Europe Idiopathic Pulmonary Fibrosis Market, By Route of Administration Overview
6.5.2 Europe Idiopathic Pulmonary Fibrosis Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
6.5.3 Europe Idiopathic Pulmonary Fibrosis Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
6.5.4 Europe Idiopathic Pulmonary Fibrosis Market Size, By Other ROA, By Value, 2018H-2028F (USD Million & CAGR)
6.6 Europe Idiopathic Pulmonary Fibrosis Market Segmentation: By Distribution Channel
6.6.1 Europe Idiopathic Pulmonary Fibrosis Market, By Distribution Channel Overview
6.6.2 Europe Idiopathic Pulmonary Fibrosis Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
6.6.3 Europe Idiopathic Pulmonary Fibrosis Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
6.7 Europe Idiopathic Pulmonary Fibrosis Market Segmentation: By Country
6.7.1 France Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.1.1 France Idiopathic Pulmonary Fibrosis Market, By Drug Type
6.7.1.2 France Idiopathic Pulmonary Fibrosis Market, By Route of Administration
6.7.1.3 France Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
6.7.2 United Kingdom Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.2.1 United Kingdom Idiopathic Pulmonary Fibrosis Market, By Drug Type
6.7.2.2 United Kingdom Idiopathic Pulmonary Fibrosis Market, By Route of Administration
6.7.2.3 United Kingdom Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
6.7.3 Italy Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.3.1 Italy Idiopathic Pulmonary Fibrosis Market, By Drug Type
6.7.3.2 Italy Idiopathic Pulmonary Fibrosis Market, By Route of Administration
6.7.3.3 Italy Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
6.7.4 Spain Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.4.1 Spain Idiopathic Pulmonary Fibrosis Market, By Drug Type
6.7.4.2 Spain Idiopathic Pulmonary Fibrosis Market, By Route of Administration
6.7.4.3 Spain Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
6.7.5 Germany Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.5.1 Germany Idiopathic Pulmonary Fibrosis Market, By Drug Type
6.7.5.2 Germany Idiopathic Pulmonary Fibrosis Market, By Route of Administration
6.7.5.3 Germany Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
6.7.6 Rest of Europe Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.6.1 Rest of Europe Idiopathic Pulmonary Fibrosis Market, By Drug Type
6.7.6.2 Rest of Europe Idiopathic Pulmonary Fibrosis Market, By Route of Administration
6.7.6.3 Rest of Europe Idiopathic Pulmonary Fibrosis Market, By Distribution Channel

7. Asia-Pacific Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)

7.1 Asia-Pacific Idiopathic Pulmonary Fibrosis Market: Snapshot
7.2 Asia-Pacific Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.3 Asia-Pacific Idiopathic Pulmonary Fibrosis Market: Key Factors
7.4 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Segmentation: By Drug Type
7.4.1 Asia-Pacific Idiopathic Pulmonary Fibrosis Market, By Drug Type Overview
7.4.2 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size, By Pirfenidone, By Value, 2018H-2028F (USD Million & CAGR)
7.4.3 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size, By Nintedanib, By Value, 2018H-2028F (USD Million & CAGR)
7.4.4 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size, By Other drugs, By Value, 2018H-2028F (USD Million & CAGR)
7.5 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Segmentation: By Route of Administration
7.5.1 Asia-Pacific Idiopathic Pulmonary Fibrosis Market, By Route of Administration Overview
7.5.2 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
7.5.3 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
7.5.4 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size, By Other ROA, By Value, 2018H-2028F (USD Million & CAGR)
7.6 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Segmentation: By Distribution Channel
7.6.1 Asia-Pacific Idiopathic Pulmonary Fibrosis Market, By Distribution Channel Overview
7.6.2 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
7.6.3 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
7.6.4 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
7.7 Asia-Pacific Idiopathic Pulmonary Fibrosis Market Segmentation: By Country
7.7.1 China Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.1.1 China Idiopathic Pulmonary Fibrosis Market, By Drug Type
7.7.1.2 China Idiopathic Pulmonary Fibrosis Market, By Route of Administration
7.7.1.3 China Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
7.7.2 Japan Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.1.1 Japan Idiopathic Pulmonary Fibrosis Market, By Drug Type
7.7.1.2 Japan Idiopathic Pulmonary Fibrosis Market, By Route of Administration
7.7.1.3 Japan Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
7.7.3 South Korea Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.3.1 South Korea Idiopathic Pulmonary Fibrosis Market, By Drug Type
7.7.3.2 South Korea Idiopathic Pulmonary Fibrosis Market, By Route of Administration
7.7.3.3 South Korea Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
7.7.4 India Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.4.1 India Idiopathic Pulmonary Fibrosis Market, By Drug Type
7.7.4.2 India Idiopathic Pulmonary Fibrosis Market, By Route of Administration
7.7.4.3 India Idiopathic Pulmonary Fibrosis Market, By Distribution Channel
7.7.5 Rest of Asia-Pacific Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.5.1 Rest of Asia-Pacific Idiopathic Pulmonary Fibrosis Market, By Drug Type
7.7.5.2 Rest of Asia-Pacific Idiopathic Pulmonary Fibrosis Market, By Route of Administration
7.7.5.3 Rest of Asia-Pacific Idiopathic Pulmonary Fibrosis Market, By Distribution Channel

8. Middle-East & Africa Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)

8.1 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market: Snapshot
8.2 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
8.3 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market: Key Factors
8.4 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Segmentation: By Drug Type
8.4.1 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market, By Drug Type Overview
8.4.2 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Size, By Pirfenidone, By Value, 2018H-2028F (USD Million & CAGR)
8.4.3 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Size, By Nintedanib, By Value, 2018H-2028F (USD Million & CAGR)
8.4.4 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Size, By Other drugs, By Value, 2018H-2028F (USD Million & CAGR)
8.5 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Segmentation: By Route of Administration
8.5.1 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market, By Route of Administration Overview
8.5.2 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
8.5.3 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
8.5.4 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Size, By Other ROA, By Value, 2018H-2028F (USD Million & CAGR)
8.6 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Segmentation: By Distribution Channel
8.6.1 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market, By Distribution Channel: Overview
8.6.2 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
8.6.3 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
8.6.4 Middle-East & Africa Idiopathic Pulmonary Fibrosis Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)

9. Market Dynamics

9.1 Impact assessment of Market Dynamics on Global Idiopathic Pulmonary Fibrosis Market
9.2 Drivers
9.3 Restraints
9.4 Trends

10. Industry Ecosystem Analysis

10.1 Macro-Economic Factor Assessment
10.2 Porter’s Five Forces Model

11. Competitive Positioning

11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Idiopathic Pulmonary Fibrosis Market
11.4 Company Profiles
11.4.1 Boehringer Ingelheim
11.4.2 F. Hoffmann-La Roche AG
11.4.3 Cipla Ltd.
11.4.4 Shionogi & Co., Ltd.
11.4.5 Bristol-Myers Squibb Co.
11.4.6 United Therapeutics
11.4.7 FibroGen, Inc.
11.4.8 Pliant Therapeutics
11.4.9 Galecto Inc.
11.4.10 CSL Behring
List of Figures
Figure 1: Most bothersome IPF symptom
Figure 2: Global IPF diagnosed prevalent cases,2023 (Millions)
Figure 3: Global Idiopathic Pulmonary Fibrosis Market Size, By Value, 2019-2022 (USD Million)
Figure 4: Global Idiopathic Pulmonary Fibrosis Market Size, By Value, 2023-2029 (USD Million)
Figure 5: Global Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, 2022 (%)
Figure 6: Global Idiopathic Pulmonary Fibrosis Market Size, By Pirfenidone, By Value, 2019H-2029F (USD Million & CAGR)
Figure 7: Global Idiopathic Pulmonary Fibrosis Market Absolute Opportunity, By Pirfenidone, 2019-2029 (USD Million)
Figure 8: Global Idiopathic Pulmonary Fibrosis Market Size, By Nintedanib, By Value, 2019H-2029F (USD Million & CAGR)
Figure 9: Global Idiopathic Pulmonary Fibrosis Market Absolute Opportunity, By Nintedanib, 2019-2029 (USD Million)
Figure 10: Global Idiopathic Pulmonary Fibrosis Market Size, By Other drugs, By Value, 2019H-2029F (USD Million & CAGR)
Figure 11: Global Idiopathic Pulmonary Fibrosis Market Absolute Opportunity, By Other drugs, 2019-2029 (USD Million)
Figure 12: Global Idiopathic Pulmonary Fibrosis Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 13: Global Idiopathic Pulmonary Fibrosis Market Absolute Opportunity, By Oral, 2019-2029 (USD Million)
Figure 14: Global Idiopathic Pulmonary Fibrosis Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 15: Global Idiopathic Pulmonary Fibrosis Market Absolute Opportunity, By Parenteral, 2019-2029 (USD Million)
Figure 16: Global Idiopathic Pulmonary Fibrosis Market Size, By Other ROA, By Value, 2019H-2029F (USD Million & CAGR)`
Figure 17: Global Idiopathic Pulmonary Fibrosis Market Absolute Opportunity, By Other ROA, 2019-2029 (USD Million)
Figure 18: Global Idiopathic Pulmonary Fibrosis Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 19: Global Idiopathic Pulmonary Fibrosis Market Absolute Opportunity, By Hospital Pharmacies, 2019-2029 (USD Million)
Figure 20: Global Idiopathic Pulmonary Fibrosis Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 21: Global Idiopathic Pulmonary Fibrosis Market Absolute Opportunity, By Retail Pharmacies, 2019-2029 (USD Million)
Figure 22: Global Idiopathic Pulmonary Fibrosis Market Size, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 23: Global Idiopathic Pulmonary Fibrosis Market Absolute Opportunity, By Online Channel, 2019-2029 (USD Million)
Figure 24: Americas Idiopathic Pulmonary Fibrosis Market Size, By Value, 2019H-2029F (USD Million)
Figure 25: Americas Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, 2022 (%)
Figure 26: Americas Idiopathic Pulmonary Fibrosis Market, By Pirfenidone, By Value, 2019H-2029F (USD Million & CAGR)
Figure 27: Americas Idiopathic Pulmonary Fibrosis Market, By Nintedanib, By Value, 2019H-2029F (USD Million & CAGR)
Figure 28: Americas Idiopathic Pulmonary Fibrosis Market, By Other drugs, By Value, 2019H-2029F (USD Million & CAGR)
Figure 29: Americas Idiopathic Pulmonary Fibrosis Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 30: Americas Idiopathic Pulmonary Fibrosis Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 31: Americas Idiopathic Pulmonary Fibrosis Market, By Other ROA, By Value, 2019H-2029F (USD Million & CAGR)
Figure 32: Americas Idiopathic Pulmonary Fibrosis Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 33: Americas Idiopathic Pulmonary Fibrosis Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 34: Americas Idiopathic Pulmonary Fibrosis Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 35: United States Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 36: United States Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 37: United States Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 38: United States Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, By Value, 2022 (%)
Figure 39: United States Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 40: Canada Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 41: Canada Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 42: Canada Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 43: Canada Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 44: Canada Idiopathic Pulmonary Fibrosis Market Share, Distribution Channel, 2022 (%)
Figure 45: Rest of Americas Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 46: Rest of Americas Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 47: Rest of Americas Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 48: Rest of Americas Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 49: Rest of Americas Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 50: Europe Idiopathic Pulmonary Fibrosis Market Size, By Value, 2019H-2029F (USD Million)
Figure 51: Europe Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, 2022 (%)
Figure 52: Europe Idiopathic Pulmonary Fibrosis Market, By Pirfenidone, By Value, 2019H-2029F (USD Million & CAGR)
Figure 53: Europe Idiopathic Pulmonary Fibrosis Market, By Nintedanib, By Value, 2019H-2029F (USD Million & CAGR)
Figure 54: Europe Idiopathic Pulmonary Fibrosis Market, By Other drugs, By Value, 2019H-2029F (USD Million & CAGR)
Figure 55: Europe Idiopathic Pulmonary Fibrosis Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 56: Europe Idiopathic Pulmonary Fibrosis Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 57: Europe Idiopathic Pulmonary Fibrosis Market, By Other ROA, By Value, 2019H-2029F (USD Million & CAGR)
Figure 58: Europe Idiopathic Pulmonary Fibrosis Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 59: Europe Idiopathic Pulmonary Fibrosis Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 60: Europe Idiopathic Pulmonary Fibrosis Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 61: France Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 62: France Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 63: France Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 64: France Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 65: France Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 66: United Kingdom Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 67: United Kingdom Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 68: United Kingdom Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 69: United Kingdom Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 70: United Kingdom Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 71: Italy Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 72: Italy Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 73: Italy Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 74: Italy Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 75: Italy Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 76: Spain Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 77: Spain Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 78: Spain Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 79: Spain Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 80: Spain Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 81: Germany Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 82: Germany Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 83: Germany Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 84: Germany Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 85: Germany Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 86: Rest of Europe Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 87: Rest of Europe Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 88: Rest of Europe Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 89: Rest of Europe Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 90: Rest of Europe Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 91: Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, By Value, 2019H-2029F (USD Million)
Figure 92: Asia Pacific Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, 2022 (%)
Figure 93: Asia Pacific Idiopathic Pulmonary Fibrosis Market, By Pirfenidone, By Value, 2019H-2029F (USD Million & CAGR)
Figure 94: Asia Pacific Idiopathic Pulmonary Fibrosis Market, By Nintedanib, By Value, 2019H-2029F (USD Million & CAGR)
Figure 95: Asia Pacific Idiopathic Pulmonary Fibrosis Market, By Other drugs, By Value, 2019H-2029F (USD Million & CAGR)
Figure 96: Asia Pacific Idiopathic Pulmonary Fibrosis Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 97: Asia Pacific Idiopathic Pulmonary Fibrosis Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 98: Asia Pacific Idiopathic Pulmonary Fibrosis Market, By Other ROA, By Value, 2019H-2029F (USD Million & CAGR)
Figure 99: Asia Pacific Idiopathic Pulmonary Fibrosis Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 100: Asia Pacific Idiopathic Pulmonary Fibrosis Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 101: Asia Pacific Idiopathic Pulmonary Fibrosis Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 102: China Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 103: China Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 104: China Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 105: China Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 106: China Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 107: Japan Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 108: Japan Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 109: Japan Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 110: Japan Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 111: Japan Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 112: South Korea Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 113: South Korea Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 114: South Korea Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 115: South Korea Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 116: South Korea Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 117: India Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 118: India Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 119: India Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 120: India Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 121: India Idiopathic Pulmonary Fibrosis Market Share, Distribution Channel, 2022 (%)
Figure 122: Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 123: Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Value, By Drug Type, 2022 (USD Million)
Figure 124: Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, By Value, 2022 (%)
Figure 125: Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Share, By Route of Administration, 2022 (%)
Figure 126: Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Share, By Distribution Channel, 2022 (%)
Figure 127: Middle East and Africa Idiopathic Pulmonary Fibrosis Market Size, By Value, 2019H-2029F (USD Million)
Figure 128: Middle East and Africa Idiopathic Pulmonary Fibrosis Market Share, By Drug Type, 2022 (%)
Figure 129: Middle East and Africa Idiopathic Pulmonary Fibrosis Market, By Pirfenidone, By Value, 2019H-2029F (USD Million & CAGR)
Figure 130 Middle East and Africa Idiopathic Pulmonary Fibrosis Market, By Nintedanib, By Value, 2019H-2029F (USD Million & CAGR)
Figure 131 Middle East and Africa Idiopathic Pulmonary Fibrosis Market, By Other drugs, By Value, 2019H-2029F (USD Million & CAGR)
Figure 132: Middle East and Africa Idiopathic Pulmonary Fibrosis Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 133: Middle East and Africa Idiopathic Pulmonary Fibrosis Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 134: Middle East and Africa Idiopathic Pulmonary Fibrosis Market, By Other ROA, By Value, 2019H-2029F (USD Million & CAGR)
Figure 135: Middle East and Africa Idiopathic Pulmonary Fibrosis Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 136: Middle East and Africa Idiopathic Pulmonary Fibrosis Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 137: Middle East and Africa Idiopathic Pulmonary Fibrosis Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 138: Global Impact of Drivers and Restraints
Figure 139: Market Share of Prominent Companies of Idiopathic Pulmonary Fibrosis Market, 2022 (%)
Figure 140: Roche Revenues, 2020-2022 (USD Million)
Figure 141: Roche Revenue , By Business Segment, 2022 (%)
Figure 142: Cipla Revenues, 2020-2022 (USD Million)
Figure 143: Cipla Revenues, By Geographic Segments, 2022 (%)
Figure 144: Cipla Revenue , By Business Segments, 2022 (%)
Figure 145: Shionogi & Co., Revenues, 2020-2022 (USD Million)
Figure 146: Shionogi & Co., Revenues, By Geographic Segments, 2022 (%)
Figure 147: Shionogi & Co., Revenue , By Therapeutic Area, 2022 (%)
Figure 148: Bristol-Myers Squibb Revenues, 2020-2022 (USD Million)
Figure 149: Bristol-Myers Squibb Revenues, By Geographic Segments, 2022 (%)
Figure 150: United Therapeutics Revenues, 2020-2022 (USD Million)
Figure 151: United Therapeutics Revenues, By Geographic Segments, 2022 (%)
Figure 152: United Therapeutics Revenues, By commercial products, 2022 (%)
Figure 153: Pliant Therapeutics Revenues, 2020-2022 (USD Thousand)
Figure 154: CSL Behring Revenues, 2020-2022 (USD Million)
Figure 155: CSL Behring Revenues, By Geographic Segments, 2022 (%)
Figure 156: CSL Behring Revenue , By Therapeutic Area, 2022 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: Competitive landscape for IPF drugs in Pipeline
Table A3: Unmet need of Patients with Chronic Cough
Table A4: Comorbid conditions associated with chronic cough in patients with IPF.
Table A5: United States Idiopathic Pulmonary Fibrosis Market, By Drug Type, By Value, 2019-2022 (USD Million)
Table A6: United States Idiopathic Pulmonary Fibrosis Market, By Drug Type, By Value, 2023-2029 (USD Million)
Table A7: United States Idiopathic Pulmonary Fibrosis Market, By Route of Administration, By Value, 2019-20

Table Information

Report Attribute	Details
No. of Pages	260
Published	July 2023
Forecast Period	2024 - 2029
Estimated Market Value ( USD ) in 2024	$ 5.9 Billion
Forecasted Market Value ( USD ) by 2029	$ 10.6 Billion
Compound Annual Growth Rate	12.6%
Regions Covered	Global

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2388EUR$2,450USD£1,990GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€2875EUR$2,950USD£2,396GBP

Scope of the Report

Table of Contents

Table Information

Related Topics

Related Reports

Nintedanib API Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Pirfenidone (CAS 53179-13-8) Global Market Research Report 2024

Idiopathic Pulmonary Fibrosis Global Market Report 2024

Idiopathic Pulmonary Fibrosis Market by Drug Type, Distribution Channel, End-User - Global Forecast 2025-2030

Idiopathic Pulmonary Fibrosis Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Type, Distribution Channel, and Geography